The session gave some insight on the Accelerating Clinical Trials in the EU (ACT EU) and the EMA Q&As on CCTs, a guidance regarding scientific aspects and the planning, set-up and submission for CTA applications, as well as conduct, reporting, analysis and interpretation of CCTs.
Five great reasons to become a TOPRA member:
Have you heard? Why not listen to one of our free podcasts to see what you’re missing?